Company Overview and News

0
India Glycols Limited - Updates

2018-07-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

0
India Glycols Limited - Shareholders meeting

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

0
India Glycols Limited - Date of payment of dividend

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

0
India Glycols Limited - Raising of Funds

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

0
India Glycols Limited - AGM/Book Closure

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

0
10th Edition of MANUFACTURING IT SUMMIT to be Held on June 14th

2018-05-25 freepressjournal.in
The Indian manufacturing sector is sprinting at a never before pace fueled by the dynamic technological innovations and a growing number of organizations are proactively adapting these emerging advancements. The manufacturing companies are moving swiftly from mass production to customized production using technology and digital platforms. What’s important to note is that, this is just one among many transformations the industry is concurring due to adaptive advancements in IT, for manufacturing.
GABRIEL INDIAGLYCO AUROPHARMA 524804 ARBQY MINDAIND 505714 500201 532539

0
10th Edition of manufacturing IT summit to be held on June 14

2018-05-25 freepressjournal.in
The 10th edition manufacturing IT summit will be held on June 14 in Mumbai. The summit is the perfect platform for C-suite executives of manufacturing companies across industries, to come together and discuss the IT trends in Indian manufacturing industry, network with peers, and build ROI-backed business relations. This summit also facilitates a marketplace for the buyers to meet with the sellers offering disruptive solutions on the emerging trends in manufacturing’s IT.
GABRIEL INDIAGLYCO AUROPHARMA 524804 ARBQY MINDAIND 505714 500201 532539

0
Manufacturing IT summit: A call for manufacturers

2018-05-23 freepressjournal.in
The Indian manufacturing sector is sprinting at a never before pace. It is fuelled by the dynamic technological innovations and a growing number of organisations that are proactively adapting these emerging advancements. The 10th edition of manufacturing IT summit which is the perfect platform for C-suite executives of manufacturing companies across industries, will take place in June 14, 2018. The executives will come together and discuss the IT trends in Indian manufacturing industry, network with peers, and build ROI-backed business relations.
GABRIEL INDIAGLYCO AUROPHARMA 524804 ARBQY MINDAIND 505714 500201 532539

0
India Glycols Limited - Raising of Funds

2018-05-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

0
India Glycols Limited - Dividend

2018-05-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

0
India Glycols Limited - Outcome of Board Meeting

2018-05-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

0
India Glycols Limited - Dividend

2018-05-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

0
India Glycols Limited - Outcome of Board Meeting

2018-05-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

0
India Glycols Limited - Appointment

2018-05-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIAGLYCO 500201

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

5h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...